FULL SUPPLEMENT: Research on Generalized Pustular Psoriasis

August 2026 | Volume 25 | Issue 8 | 63120 | Copyright © August 2026


Published online July 31, 2026

Abstract
Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening disease of immunologic dysfunction. The pathophysiology of the disease was not well understood until recently. As a result, for many decades, no directed treatments existed for GPP. Management relied on the use of conventional and biologic treatments used to treat plaque psoriasis, often with poor outcomes and significant associated risks.
 
In this issue:

Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway–Directed Management
Generalized pustular psoriasis (GPP) is a rare, chronic, severe autoinflammatory dermatosis distinguished by abrupt flares of sterile pustulation, systemic inflammation, and substantial morbidity and mortality.1-4 Once viewed as a variant of plaque psoriasis, accumulating epidemiologic, clinical, and mechanistic evidence now establishes GPP as a distinct disease entity with unique diagnostic challenges, extracutaneous manifestations, and therapeutic priorities. Patients may require ...

Read More